Shire's Gaucher's treatment granted orphan status in Australia
This article was originally published in Scrip
Executive Summary
Shire Australia's experimental Gaucher's disease treatment, velaglucerase alfa, has been granted orphan status by the Australian Therapeutics Drugs Administration (TGA).